Go Pro
→ Trump’s New Currency Reset (From Porter & Company) (Ad)tc pixel Free GMVDF Stock Alerts

G Medical Innovations (GMVDF) Competitors

$0.0001 0.00 (0.00%)
As of 08/13/2026 02:02 PM Eastern
Compare

GMVDF vs. SDCCQ, VRAYQ, TTOO, AFIB, and UTRS

Should you buy G Medical Innovations stock or one of its competitors? G Medical Innovations's main competitors and comparable companies include SmileDirectClub (SDCCQ), ViewRay (VRAYQ), T2 Biosystems (TTOO), Acutus Medical (AFIB), and Minerva Surgical (UTRS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does G Medical Innovations compare to SmileDirectClub?

G Medical Innovations (NASDAQ:GMVDF) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
SmileDirectClub N/A N/A N/A

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
SmileDirectClub Neutral

G Medical Innovations has a beta of 29.41, suggesting that its share price is 2,841% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, suggesting that its share price is 31% more volatile than the broader market.

G Medical Innovations has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.01-$24.63MN/AN/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

G Medical Innovations beats SmileDirectClub on 4 of the 6 factors compared between the two stocks.

How does G Medical Innovations compare to ViewRay?

ViewRay (NASDAQ:VRAYQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

In the previous week, ViewRay's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
ViewRay Neutral
G Medical Innovations Neutral

G Medical Innovations has lower revenue, but higher earnings than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ViewRay$102.21M0.00-$107.33MN/AN/A
G Medical Innovations$4.42M0.01-$24.63MN/AN/A

15.5% of ViewRay shares are held by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are held by institutional investors. 2.5% of ViewRay shares are held by company insiders. Comparatively, 37.1% of G Medical Innovations shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

ViewRay has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, G Medical Innovations has a beta of 29.41, indicating that its stock price is 2,841% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
ViewRayN/A N/A N/A
G Medical Innovations N/A N/A N/A

Summary

G Medical Innovations beats ViewRay on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to T2 Biosystems?

T2 Biosystems (NASDAQ:TTOO) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

In the previous week, T2 Biosystems' average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
T2 Biosystems Neutral
G Medical Innovations Neutral

G Medical Innovations has lower revenue, but higher earnings than T2 Biosystems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A
G Medical Innovations$4.42M0.01-$24.63MN/AN/A

G Medical Innovations has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
T2 Biosystems-563.16% N/A -174.06%
G Medical Innovations N/A N/A N/A

23.2% of T2 Biosystems shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 0.0% of T2 Biosystems shares are owned by company insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

T2 Biosystems has a beta of 7.75, meaning that its stock price is 675% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 29.41, meaning that its stock price is 2,841% more volatile than the broader market.

Summary

G Medical Innovations beats T2 Biosystems on 6 of the 8 factors compared between the two stocks.

How does G Medical Innovations compare to Acutus Medical?

G Medical Innovations (NASDAQ:GMVDF) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

G Medical Innovations has a beta of 29.41, suggesting that its stock price is 2,841% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.7, suggesting that its stock price is 470% more volatile than the broader market.

G Medical Innovations has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. G Medical Innovations' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

G Medical Innovations has higher earnings, but lower revenue than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.01-$24.63MN/AN/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
Acutus Medical Neutral

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by company insiders. Comparatively, 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

G Medical Innovations beats Acutus Medical on 7 of the 9 factors compared between the two stocks.

How does G Medical Innovations compare to Minerva Surgical?

G Medical Innovations (NASDAQ:GMVDF) and Minerva Surgical (NASDAQ:UTRS) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

G Medical Innovations has a beta of 29.41, indicating that its stock price is 2,841% more volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.41, indicating that its stock price is 141% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
Minerva Surgical N/A N/A N/A

G Medical Innovations has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.01-$24.63MN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A

6.0% of G Medical Innovations shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by insiders. Comparatively, 8.5% of Minerva Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
Minerva Surgical Neutral

Summary

G Medical Innovations beats Minerva Surgical on 4 of the 5 factors compared between the two stocks.

Get G Medical Innovations News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMVDF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMVDF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMVDF vs. The Competition

Export
MetricG Medical InnovationsHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$26K$5.95B$7.06B$13.10B
Dividend YieldN/A1.76%2.57%10.45%
P/E RatioN/A26.22269.0625.28
Price / Sales0.0163.24592.9687.71
Price / CashN/A33.9270.4850.90
Price / BookN/A6.1012.916.24
Net Income-$24.63M$148.67M$3.45B$347.60M
7 Day PerformanceN/A1.84%1.12%1.07%
1 Month PerformanceN/A4.56%1.79%1.03%
1 Year PerformanceN/A8.67%67.69%20.77%

G Medical Innovations Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMVDF
G Medical Innovations
N/A$0.00
flat		N/AN/A$26K$4.42MN/A72
SDCCQ
SmileDirectClub
N/AN/AN/AN/A$40K$470.74MN/A2,700
VRAYQ
ViewRay
N/AN/AN/AN/A$16K$102.21MN/A300
TTOO
T2 Biosystems
N/A$0.00
flat		N/A-95.5%$11K$7.68MN/A180
AFIB
Acutus Medical
N/A$0.00
-50.0%		N/A-80.0%$3K$7.16MN/A340

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GMVDF) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Buy These Stocks Before August 31st
Keith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwi...
TradeSmith | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel